Use of factor XIII for stimulating the perfusion of ischemic tissue
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 19, 2007
app pub date -
Feb 15, 2005
filing date -
Feb 20, 2004
priority date (Note) -
Abandoned
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Abstract
Subject of the present invention is the use of a Factor XIII-preparation preferably in injectable form for the treatment of diseases which are associated with disturbed blood perfusion of the tissue following transient or permanent ischemia.
First Claim
all claims..Other Claims data not available
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
CSL BEHRING GMBH | EMIL VON BEHRING STRASSE 76 D-35041 MARBURG |
International Classification(s)

- 2005 Application Filing Year
- A61K Class
- 9209 Applications Filed
- 3991 Patents Issued To-Date
- 43.34 % Issued To-Date
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Dardik, Rima | Rishon Le Zion, IL | 1 | 1 |
# of filed Patents : 1 Total Citations : 1 | |||
Dickneite, Gerhard | Marburg, DE | 37 | 360 |
# of filed Patents : 37 Total Citations : 360 | |||
Inbal, Aida | Hod Hasharon, IL | 4 | 6 |
# of filed Patents : 4 Total Citations : 6 | |||
Leor, Jonathan | Gane-Tikva, IL | 15 | 263 |
# of filed Patents : 15 Total Citations : 263 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 1 Citation Count
- A61K Class
- 8.93 % this patent is cited more than
- 18 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events
- No Legal Status data available.

Matter Detail

Renewals Detail
